What Is Care Orchestration in Cancer Care Operations?

Gray logo and the words "What is care orchestration? In cancer care operations" on a dark blue network background.

Every day, a cancer center has to fit incoming patients into a limited number of linac slots, infusion chairs, consult hours and staff, appointment by appointment, across departments that each work from their own system and their own rules. For years that work was absorbed by experienced schedulers and the spreadsheets they kept on the side. With demand rising and staffing tighter in nearly every clinical and technical role, it has become much harder to absorb, and the strain now surfaces in delayed treatment starts and in capacity that leadership suspects is there but cannot locate.

Care orchestration is the work of matching patient demand to finite capacity across the whole institution. Every cancer center already does it, mostly by hand. This article lays out what it involves, why it has become so hard to sustain, and how a care orchestration platform changes it.

Definition

Care orchestration is the management of patient demand against finite capacity across every department, resource and dependency of a cancer center, rebalanced as conditions change. A care orchestration platform is the infrastructure that supports this work, alongside the EHR and OIS, as the cancer center's system of operations.


Why cancer care needs a new operational layer

The pressure on cancer center operations comes from four directions at once, and each has been measured and managed on its own for years. What has changed is that they now feed into one another.

Demand is rising on two clocks. The US now records more than two million new cancer diagnoses a year, roughly 5,600 a day (ACS, Cancer Statistics 2025). Europe is expected to pass 3.24 million new cases a year by 2040 (ECIS/GLOBOCAN), and France projects up to 600,000 by 2050 (INCa, Panorama 2024). Prevalence weighs even more on operations, because patients now stay in the system long after treatment. 18.6 million Americans were living with a history of cancer at the start of 2025, a figure expected to pass 22 million by 2035 (ACS, Survivorship Statistics 2025), and each of them still needs clinic time and imaging slots, sometimes for decades.

Each patient carries more coordination. In a UK analysis of curative-intent treatment, 45 percent of patients received two modalities and 13 percent received all three (FORTY project, BJR 2023), so a single trajectory routinely crosses departments that were built to run independently.

The workforce has not kept up. 21 percent of the US medical oncologists practicing in 2015 had left clinical care by 2022 (ASCO, JCO OP 2025), and 93 percent of radiation oncology practices reported staffing shortages in 2023, more than half of them already delaying treatment (ONS). In the UK, the NHS runs a 15 percent shortfall in oncology consultants, projected to reach 19 percent by 2029 (King's Fund, 2026). [LINK: article main-d'œuvre]

The financial cushion has thinned. Every one of 100 US health system leaders surveyed in January 2025 expected operating margins of 1 to 2 percent to become the norm (Becker's/LeanTaaS). Public systems get there through deficits, with 69 percent of acute NHS trusts in the red in 2024/25 (King's Fund) and 70 percent of French public hospitals in 2024 (DREES). Two very different systems landing within a point of each other is about as clear a sign as you get that this is structural.

Lorrie Reynolds, who leads the regional cancer program at Southlake Regional Health Centre in Ontario, describes the public-system version of this in terms most leaders will recognize.

"We are seeing rising volumes of cancer patients across our region, year after year, and in a public system we cannot always add machines, chairs, or staff at the same pace. Our responsibility is to make sure the capacity we already have reaches patients, close to home and on time, because for our communities access is measured in wait times."

Put together, the four pressures compound. Rising demand strains a workforce that cannot grow fast enough, that strain eats into budgets that are already thin, and the lack of budget blocks the investment that would help absorb more complex care. The workarounds most centers rely on to hold this together were never designed for that kind of load, and that is where the strain becomes visible on the floor.

/

Test


What the strain looks like on the floor

Radiation therapy is one place where this shows up clearly. When the team at The Ottawa Hospital described their daily work, one phrase kept coming back: "We're operating in the dark." The schedule leadership looked at was a different schedule from the one being run on the floor, and the capacity it reported did not match the capacity in use. Decisions that should have been routine, like approving a PTO request three weeks out or taking a machine down for maintenance on a given shift, turned into educated guesses, because the data that should have informed them sat in departments that shared no common view.

Most cancer centers would recognize that description, in radiation therapy and well beyond it. Last-minute change is the normal state of the day. An urgent case comes out of tumor board, a morning lab result cancels an infusion, two therapists call in sick, a linac goes down mid-morning and takes dozens of fractions with it. The systems in place were built to record appointments, so when the day moves, the schedule degrades and someone rebuilds it by hand.

That rebuilding happens in places no performance report ever sees. Spreadsheets kept on a shared drive, whiteboards, printed lists annotated in pen, sticky notes on the edge of a monitor, phone calls and hallway conversations between departments. It also depends on a small number of experienced people who know which appointment combinations will cascade, how to recover from a disruption without breaking a clinical constraint, and which patients cannot be moved one more time. When they are on vacation the department feels it within days. When they leave, most of what they knew leaves with them. All of this is care orchestration. It is simply being done by hand, by people, without infrastructure underneath it.

Sotirios Stathakis, Chief of Physics at Mary Bird Perkins Cancer Center in Louisiana, watched this play out with his own team before they changed how they scheduled.

"My most experienced therapists were spending their days fitting schedules together like a puzzle, often with the patient waiting on the phone. If the availability did not match, they hung up, reworked the whole thing, and called the patient back. That is not what twenty years of clinical expertise is for."

Part of what makes this knowledge so hard to transfer is that it is clinical and administrative at the same time. Deciding whether to defer a treatment or slot in an urgent case means holding the protocol constraints and the operational reality in one head. Two reference centers have answered that in opposite ways. At Gustave Roussy, near Paris, scheduling sits with a dedicated administrative team that escalates clinical questions to clinicians as they come up. At the CHUM in Montréal, radiation therapists own the scheduling, because the team concluded the work could not be separated from clinical judgment. Both are thoughtful choices made by serious institutions, and both carry a cost, either in escalations that pull clinicians away from patients or in clinical staff spending part of their week on administrative work. The current technology stack offers neither of them a third option. [LINK: WP-A4]

A medical oncologist at the University of Pennsylvania put the same tension more bluntly: "We're asking non-clinical people to make clinical decisions when determining a patient's start date."

The cost of all this is real, even if only part of it can be measured. A 2020 BMJ meta-analysis covering 1.27 million patients found that each four-week delay in starting cancer treatment is associated with higher mortality in 13 of the 17 indications studied (Hanna et al., BMJ 2020). Some of those delays originate in clinical decision-making, and some originate in the layer where the schedule gets built. [LINK: E1] The patient feels it long before any statistic does. As Stathakis puts it, "You have just been told you have cancer, and the center cannot yet tell you when treatment starts. Every callback, every reshuffled appointment signals to the patient that the system is improvising." On the workforce side, replacing a single bedside RN now costs US hospitals an average of $61,110 (NSI, 2025), and scheduling-driven workload imbalance is one of the contributors to attrition that centers can actually act on. Capacity is the hardest cost to pin down. When the NCCN looked at infusion efficiency across its member institutions, patient wait times ranged from 25 to 102 minutes (Sugalski et al., JCO OP 2019), and the workgroup existed in the first place because nobody had a shared baseline for what good looked like.

The gap existing systems were not built to close

The capacity-demand equation runs at two levels. Inside a single department, radiation oncology has to reconcile treatment fractions against linac time, therapist coverage and dosimetry throughput, while systemic therapy works out chairs, nurse acuity, pharmacy lead times and lab validity windows. Across the institution, a patient's trajectory moves between those departments, and the handoffs are part of the equation too. When a patient finishes chemotherapy, the radiation start date depends on their clinical readiness and on what the radiation department can absorb that week.

Almost all the operational improvement work of the past twenty years has gone into the first level. Projects to improve radiation therapy scheduling or infusion scheduling, usually through template optimization or utilization studies on a single resource, have produced real gains inside department walls. The second level has had very little, and neither level can be fully solved without the other.

Two things make the institutional level so hard to reach. The first is visibility. A radiation oncology scheduler working in the OIS sees linac availability and plan readiness. A systemic therapy scheduler working in the EHR sees chairs and pharmacy timing. Neither sees the other's queue, so coordination runs through phone calls, emails and standing meetings. The second is the model itself. Reconciling dozens of clinical and operational constraints is already demanding inside one department, and doing it across several, while rebalancing every time a cancellation cascades or a machine goes down, is a different order of problem. [LINK: WP-C3]

Booking a single appointment already involves more than most people outside the department assume. "People think that booking an appointment in a hospital is simple, but actually it's ultra-complicated," said Kathy Malas, then Associate to the President and CEO for Innovation and AI at the CHUM in Montréal. "There are upwards of 25 variables to consider so that the people who are responsible for these appointments, the health-care technicians or administrative agents, can book one."


The technology most centers run on reflects how the problem grew. At the base there is still a lot of manual work, in spreadsheets and on whiteboards, even in well-resourced centers. Above that, the EHR and the OIS have absorbed scheduling functions over two decades and become the de facto system of record for appointments, though neither was built with an optimization engine. Karine Lepage, Associate Director of Nursing for Oncology at the Jewish General Hospital in Montréal, described the limit precisely: "We were able to move an individual appointment to different spots in the schedule, but the software didn't help us decide what would be most efficient. There was no digital decision-making capability." The most advanced layer is the template-based scheduling tool, which has shown that schedule optimization is tractable, especially for smoothing peak load in infusion. Its templates are refreshed every few months, its integration with the EHR is usually read-only, so schedulers re-enter bookings by hand, and it optimizes one domain at a time. [LINK: WP-A2] [LINK: Idées reçues « On a déjà un OIS »]

Gray est une entreprise de technologie en santé dont la mission est d’aider les équipes de soins à surmonter la complexité opérationnelle, afin que chaque patient reçoive les meilleurs soins possibles avec la plus grande efficacité.

André Diamant

Cofondateur & PDG

Gray est une entreprise de technologie en santé dont la mission est d’aider les équipes de soins à surmonter la complexité opérationnelle, afin que chaque patient reçoive les meilleurs soins possibles avec la plus grande efficacité.

André Diamant

Cofondateur & PDG

Prêt à Optimiser les Opérations de Votre Centre?

Prêt à Optimiser les Opérations de Votre Centre?